PATI Games Corporation (KOSDAQ:A194510) agreed to acquire a 12.59% stake in Biogenicskorea Co., Ltd. from SR I&D Co., Ltd for KRW 9.5 billion on September 25, 2017. Under the terms of the transaction, PATI Games Corporation will acquire 0.13 million shares of Biogenicskorea Co., Ltd. from SR I&D Co., Ltd at KRW 50,000 per share and subscribe to 0.06 million new shares of Biogenicskorea Co., Ltd. at KRW 50,000 per share. Post completion of the acquisition and subscription, PATI Games Corporation will hold 12.11% stake in Biogenicskorea Co., Ltd. For the year ended December 31, 2016, Biogenicskorea Co., Ltd. had total assets of KRW 6.4 billion, total capital of KRW 3.9 billion, sales of KRW 7.4 billion and net loss of KRW 788 million. The transaction was resolved by the Board of Directors of PATI Games Corporation on September 25, 2017. The transaction is expected to close on September 26, 2017. As of September 27, 2017, the transaction is expected to close on September 27, 2017.